Navigation Links
Einstein joins the New York Genome Center as 12th institutional founding member
Date:4/11/2013

April 11, 2013 (BRONX, NY) Albert Einstein College of Medicine of Yeshiva University will join the New York Genome Center (NYGC) as its twelfth Institutional Founding Member (IFM). A collaboration among leading academic medical centers, research universities and commercial organizations, NYGC aims to transform medical research and clinical care by creating one of the largest genomics research facilities in North America.

"Einstein is pleased to join other leading biomedical research institutions as a founding member," said Allen M. Spiegel, M.D., the Marilyn and Stanley M. Katz Dean. "Working together, we can significantly improve our understanding of genetics and help transform biomedical research with the goal of better understanding disease and improving patient care."

NYGC represents an unprecedented sharing of data and resources among premier institutions, which will pave the way for advances in personalized medicine, accelerate the development of new diagnostics and treatments for human diseases, and provide an engine for life science commercialization in the region.

"Albert Einstein College of Medicine has been involved with the New York Genome Center since its very inception," said Robert B. Darnell, M.D., Ph.D., president & scientific director of NYGC. "We are thrilled to formalize our relationship with this prestigious institution and have its researchers participate in the vibrant life of the center."

NYGC's other IFMs include: Cold Spring Harbor Laboratory, Columbia University, Cornell University/Weill Cornell Medical College, The Jackson Laboratory, Memorial Sloan-Kettering Cancer Center, Mount Sinai Medical Center, NewYork-Presbyterian Hospital, New York University/NYU School of Medicine, North Shore-LIJ Health System, The Rockefeller University, and Stony Brook University.


'/>"/>

Contact: Kim Newman
sciencenews@einstein.yu.edu
718-430-3101
Albert Einstein College of Medicine
Source:Eurekalert

Related biology news :

1. Feinstein Institute collaborates with GSK, UPenn, MIT to research bodys electrical impulses
2. Einstein study reveals new approach for stopping herpes infections
3. Einstein receives $12 million grant to develop device for preventing HIV infection
4. Einstein researchers receive 2 Grand Challenges Explorations grants to combat HIV and TB
5. Feinstein Institute receives $1 million grant to study impact of World Trade Center attacks on responders
6. Einstein hosts its first stem cell institute symposium
7. Einstein researcher receives $10.8 million grant to study toxic blood reactions caused by hemoglobin
8. Denmark joins the Nordic EMBL Partnership for Molecular Medicine
9. Warren Lammert Joins IntelliMedix Board of Advisors
10. FASEB joins President Obama in urging Congress to sustain investments in research and innovation
11. Book shows evolution that joins human and environmental sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/20/2017)... , March 20, 2017 PMD Healthcare announces ... spirometer and Wellness Management System (WMS), a remote, real-time ... in 2010, PMD Healthcare is a Medical Device, Digital ... mission dedicated to creating innovative solutions that empower people ... that intent focus, PMD developed the first ever personal ...
(Date:3/13/2017)... Future of security: Biometric Face Matching software  ... ... enables to match face pictures against each other or against large databases. The ... ... fastest software for biometric Face Matching on the market. The speed is at ...
(Date:3/9/2017)... MOUNTAIN VIEW, Calif. , March 9, 2017 /PRNewswire/ ... 23andMe , the leading personal genetics company, are ... can now provide customers with personalized nutrition plans that ... biometrics, but also genetic markers impacting how their body ... personalized food decision support platform uses biometrics such as ...
Breaking Biology News(10 mins):
(Date:3/30/2017)... , March 30, 2017  Jazz Pharmaceuticals plc (Nasdaq: ... entered into license agreements with Nippon Shinyaku, Co., Ltd. ... (cytarabine and daunorubicin liposome injection), or CPX-351, in ... terms of the agreements, Nippon Shinyaku will receive exclusive ... Japan in return for an ...
(Date:3/30/2017)... Personal Genome Diagnostics Inc. (PGDx) today announced that it has ... Research (AACR) Annual Meeting 2017, being held April 1-5, 2017, ... announced that five scientists associated with PGDx—two co-founders and three ... Team Science Award. ... Doug Ward , CEO of Personal Genome ...
(Date:3/29/2017)... ... March 29, 2017 , ... The ... to finding cures for inflammatory bowel diseases (IBD), and ReachMD , the ... exclusive content to ReachMD learners. , The partnership, which launched in the ...
(Date:3/29/2017)... Texas, March 29, 2017  Vermillion, Inc. (NASDAQ: ... disease, reported on its results for the fourth ... "2016 marked a pivotal year for ... guideline inclusion, international distribution agreements, major reimbursement progress ... network payer agreements. In addition we cleared our ...
Breaking Biology Technology: